IMM 11.9% 29.5¢ immutep limited

dndn earnings, page-16

  1. 5,330 Posts.
    lightbulb Created with Sketch. 32
    Hi orionwoo,

    I've felt a long term effection for Prima's promising technology platforms, and furthermore this extends past principle product, CVac and also Cripto-1, as their early stage research into innovative oral delivery systems for cervical cancer vaccines also holds some exciting promise imo.

    As you're probably already aware these research developments are being part funded by the Australian Research Council and involve world renoun Prof Ian frazer, the developer of the worlds first cervical cancer vaccine who is also the brother of Prima's Executive Director and Chief Medical Officer, the great Dr Neil Frazer

    Although we can still appreciate earlier programs carry a far greater risk factor, developing a safe and effective cancer vaccine for delivery via the oral route would be a significant scientific breakthrough, and one couldn't ask for a more dedicated team of experts to be working on this project.

    You might also be interested to learn that one of Prof Frazer's good colleagues, world renown nanotechnology expert, Prof Max Lu is also collaborating on this oral delivery system project - Prof Lu was the only Australian to make Phoenix Weekly’s list of the top 50 most influential Chinese in the world.

    He is also the director of the Australian Research Council Centre for functional Nanomaterials.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
-0.040(11.9%)
Mkt cap ! $428.5M
Open High Low Value Volume
32.0¢ 33.0¢ 28.0¢ $7.278M 23.75M

Buyers (Bids)

No. Vol. Price($)
4 53192 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 41048 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.